4Hincapie JP, Castrillon CA, Yepes FL, et al, Microbiological effects of periodontal therapy plus azithromycin in patients with diabetes: results from a randomized clinical trial [ J ]. Acta Odontol Latinoam, 2014,27( 2): 89-95.
5Zarogoulidis P, Papanas N, Kinumis I, et al. Macrolides : from in vitro anti-inflammatory and immunomodulatory properties to clinical practice in respiratory diseases[ J]. Eur J Clin Pharmacol,2012, 68 ( 5 ) :479-503.
6Toledo Junior A, Daher AB, Amaral TA, et al. Poor response to azithromycin in cutaneous leishmaniasis leading to a premature interruption of a multicentric phase l~ clinical trial in Brazil [ J ]. Rev Soc Bras Med Trop,2014,47 ( 6 ) :756-762.
7Ray WA, Murray KT, Hall K, et al. Azithromyein and t he risk of cardiovascular death [ J ]. N Engl J Med, 2012, 366 20 ) : 1881-1890.
8Langley JM, Halperin SA, Boucher FD, et al. Azithromycin is as effective as and better tolerated than erythromycin estolate for the treatment of pertussis[ J] Pediatrics,2004,114( 1 ) : e96-e101.
9Amsden GW, Baird IM, Simon S, et al. Efficacyand safety of azithromyein vs levofloxacin in the out patients treatment of acute bacterial exacerbations of chronic bronchitis [ J ]. Chest, 2003,123 (3) :772-777.
10Fowler S, Webber A, Cooper BS, et al. Sueeesaful use of feedback to improve antibiotic prescribing and reduce Clostridium diffiele infection: a controlled interrupted time series [ J ]. J Antimicrob Chemother,2007,59 ( 5 ) :990-995.